CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

UTI Healthcare Fund-Reg(G)

very highequitypharma & health care
221.93 1.17(0.53%) NAV as on 24 Apr 2024
0.79 % 1 M
49.28 % 1 Y
13.74 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.33

As on 31 Mar, 2024
age-icon Age :

18 yrs 8 m

Since 01 08 ,2005
exit_load Exit Load :

1%

aum AUM :

947.26 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

6.77

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

S&P BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Kamal Gada

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2024
Debt 0.13 %
Others 0.53 %
Equity 99.34 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.56 %
Cipla Ltd.7.15 %
Apollo Hospitals Enterprise Ltd.6.88 %
Ajanta Pharma Ltd.5.91 %
Dr. Reddy's Laboratories Ltd.5.49 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs74.38
Hospital & Healthcare Services21.77
Business Support1.58
Medical Equipment/Supplies/Accessories1.05
Insurance0.57
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)80.12139.38157.00143.40223.40
Net Assets(Rs Crores) (as on 31-Mar-2024) 360.08 618.13 776.23 654.50 947.26
Scheme Returns(%)(Absolute)-7.1376.1912.06-8.8155.54
B'mark Returns(%)(Absolute)NANANANANA
Category Rank16/7535/7550/7568/7621/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

UTI Healthcare Fund-Reg(G)Very HighEquity221.931.17(0.53%)NAV As on 24 Apr, 202401-Aug-2005Inception Date947.26AUM In Cr.49.28%1Y13.74%3Y20.72%5Y17.98%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity343.652.81(0.82%)NAV As on 24 Apr, 202414-Jul-1999Inception Date2,626.34AUM In Cr.53.91%1Y17.73%3Y23.10%5Y16.10%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity30.300.10(0.33%)NAV As on 24 Apr, 202413-Jul-2018Inception Date3,772.32AUM In Cr.56.83%1Y17.44%3Y24.10%5Y21.12%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.220.20(0.64%)NAV As on 24 Apr, 202430-Nov-2018Inception Date2,352.32AUM In Cr.49.84%1Y16.22%3Y25.28%5Y24.18%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity24.760.09(0.38%)NAV As on 24 Apr, 202428-Dec-2015Inception Date878.70AUM In Cr.51.01%1Y15.91%3Y21.81%5Y11.50%Since Inception
Nippon India Pharma Fund(G)Very HighEquity422.622.47(0.59%)NAV As on 24 Apr, 202405-Jun-2004Inception Date7,125.28AUM In Cr.50.73%1Y15.63%3Y22.36%5Y20.70%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.